These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 17007085)
1. The biochemical mechanisms of oncogene action: cell surface receptors. Cancer J Sci Am; 1996; 2(6):360-1. PubMed ID: 17007085 [No Abstract] [Full Text] [Related]
2. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit? Felsher DW Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131 [TBL] [Abstract][Full Text] [Related]
3. Nanomagnetic actuation of receptor-mediated signal transduction. Mannix RJ; Kumar S; Cassiola F; Montoya-Zavala M; Feinstein E; Prentiss M; Ingber DE Nat Nanotechnol; 2008 Jan; 3(1):36-40. PubMed ID: 18654448 [TBL] [Abstract][Full Text] [Related]
4. New paradigms in signal transduction. Eyster KM Biochem Pharmacol; 2007 May; 73(10):1511-9. PubMed ID: 17097069 [TBL] [Abstract][Full Text] [Related]
5. Oncogenes on my mind: ERK and MTOR signaling in cognitive diseases. Krab LC; Goorden SM; Elgersma Y Trends Genet; 2008 Oct; 24(10):498-510. PubMed ID: 18774199 [TBL] [Abstract][Full Text] [Related]
6. Proteomics of membrane receptors and signaling. Kabbani N Proteomics; 2008 Oct; 8(19):4146-55. PubMed ID: 18763708 [TBL] [Abstract][Full Text] [Related]
8. Oncogene addiction. Weinstein IB; Joe A Cancer Res; 2008 May; 68(9):3077-80; discussion 3080. PubMed ID: 18451130 [TBL] [Abstract][Full Text] [Related]
9. 5th International Symposium on receptor mechanisms, signal transduction and drug effects. Yamada S; Ehlert FJ; Hollenberg MD Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):267-8. PubMed ID: 18357439 [No Abstract] [Full Text] [Related]
10. Cross-talk between integrins and oncogenes modulates chemosensitivity. Puigvert JC; Huveneers S; Fredriksson L; op het Veld M; van de Water B; Danen EH Mol Pharmacol; 2009 Apr; 75(4):947-55. PubMed ID: 19158362 [TBL] [Abstract][Full Text] [Related]
12. Oncogenic pathways impinging on the G2-restriction point. Foijer F; Simonis M; van Vliet M; Wessels L; Kerkhoven R; Sorger PK; Te Riele H Oncogene; 2008 Feb; 27(8):1142-54. PubMed ID: 17700522 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of axon guidance: membrane dynamics and axonal transport in semaphorin signalling. Mann F; Rougon G J Neurochem; 2007 Jul; 102(2):316-23. PubMed ID: 17442048 [TBL] [Abstract][Full Text] [Related]
14. Positioning of chemosensory clusters in E. coli and its relation to cell division. Thiem S; Kentner D; Sourjik V EMBO J; 2007 Mar; 26(6):1615-23. PubMed ID: 17332753 [TBL] [Abstract][Full Text] [Related]
16. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Schefe JH; Menk M; Reinemund J; Effertz K; Hobbs RM; Pandolfi PP; Ruiz P; Unger T; Funke-Kaiser H Circ Res; 2006 Dec; 99(12):1355-66. PubMed ID: 17082479 [TBL] [Abstract][Full Text] [Related]
17. LRP6 as a candidate oncogene that regulates tumor proliferation. Cancer Biol Ther; 2004 Dec; 3(12):1193. PubMed ID: 15871142 [No Abstract] [Full Text] [Related]
18. Enhanced exocytosis of the receptor BT-R(1) induced by the Cry1Ab toxin of Bacillus thuringiensis directly correlates to the execution of cell death. Zhang X; Griko NB; Corona SK; Bulla LA Comp Biochem Physiol B Biochem Mol Biol; 2008 Apr; 149(4):581-8. PubMed ID: 18230416 [TBL] [Abstract][Full Text] [Related]
19. Oligodendrocytes: Susceptibility to injury and involvement in neurologic disease. Benarroch EE Neurology; 2009 May; 72(20):1779-85. PubMed ID: 19451534 [No Abstract] [Full Text] [Related]